SCEN - Seattle Genetics Inc /wa - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - SCEN (1060736)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
70 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-11-10
SGENEpstein David RCEOS - Sale$213.01-10,620136,598-7%-$2,262,166
2023-11-09
SGENHimes Vaughn BChief Technical OfficerS - Sale$213.32-8,785162,045-5%-$1,874,053
2023-09-21
SGENDansey Roger DPres, R, D, CMOS - Sale$206.50-71116,6770%-$14,662
2023-09-21
SGENHimes Vaughn BChief Technical OfficerS - Sale$206.50-80170,8300%-$16,520
2023-09-21
SGENLiu Jean IGCS - Sale$206.50-6484,3980%-$13,216
2023-09-21
SGENRomp Charles REVP, Commercial U.S.S - Sale$206.50-4569,1110%-$9,293
2023-09-21
SGENSimpson Todd ECFOS - Sale$206.50-80128,7230%-$16,520
D
2023-09-07
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$205.76-8,785170,910-5%-$1,807,602
2023-08-31
SGENDansey Roger DPres, R, D, CMOS - Sale$206.97-4,029111,768-3%-$833,866
2023-08-31
SGENHimes Vaughn BChief Technical OfficerS - Sale$206.97-1,795170,910-1%-$371,504
2023-08-31
SGENLiu Jean IGCS - Sale$206.97-1,89384,462-2%-$391,786
2023-08-31
SGENRomp Charles REVP, Commercial U.S.S - Sale$206.97-55569,156-1%-$114,866
2023-08-31
SGENSimpson Todd ECFOS - Sale$206.97-2,122128,803-2%-$439,182
2023-08-29
SGENDansey Roger DPres, R, D, CMOS - Sale$206.00-1,016115,797-1%-$209,296
2023-08-29
SGENHimes Vaughn BChief Technical OfficerS - Sale$206.00-371172,7050%-$76,426
2023-08-29
SGENRomp Charles REVP, Commercial U.S.S - Sale$206.00-43869,711-1%-$90,228
2023-08-29
SGENSimpson Todd ECFOS - Sale$206.00-485130,9250%-$99,910
2023-08-29
SGENLiu Jean IGCS - Sale$206.00-40586,3550%-$83,430
D
2023-08-28
SGENWelch Daniel GDirS - Sale+OE$209.08-4,92517,519-22%-$1,029,712
2023-07-03
SGENRomp Charles REVP, Commercial U.S.S - Sale$192.46-70859,069-1%-$136,262
D
2023-06-07
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$195.29-16,215163,308-9%-$3,166,571
2023-05-16
SGENRomp Charles REVP, Commercial U.S.S - Sale$189.86-34959,777-1%-$66,261
D
2023-05-15
SGENWelch Daniel GDirS - Sale+OE$200.02-1,86418,588-9%-$372,837
DM
2023-05-01
SGENWelch Daniel GDirS - Sale+OE$200.07-27,03218,588-59%-$5,408,188
D
2023-04-17
SGENLiu Jean IGCS - Sale+OE$205.86-5,00086,763-5%-$1,029,311
D
2023-04-17
SGENDansey Roger DPres, R, D, CMOS - Sale+OE$205.95-10,00099,389-9%-$2,059,488
D
2023-04-10
SGENSimpson Todd ECFOS - Sale+OE$204.58-55,344118,946-32%-$11,322,143
2023-04-06
SGENSimpson Todd ECFOS - Sale$205.86-243118,9460%-$50,023
2023-04-06
SGENRomp Charles REVP, Commercial U.S.S - Sale$205.86-13360,1260%-$27,379
2023-04-06
SGENLiu Jean IGCS - Sale$205.86-17486,7630%-$35,819
2023-04-06
SGENHimes Vaughn BChief Technical OfficerS - Sale$205.86-243188,3080%-$50,023
2023-04-06
SGENDansey Roger DPres, R, D, CMOS - Sale$205.86-33399,3890%-$68,550
D
2023-04-03
SGENWelch Daniel GDirS - Sale+OE$201.61-31,00016,484-65%-$6,249,844
D
2023-03-16
SGENLiu Jean IGCS - Sale+OE$199.90-5,00085,113-6%-$999,500
D
2023-03-15
SGENWelch Daniel GDirS - Sale+OE$200.05-3,60329,959-11%-$720,780
D
2023-03-15
SGENDansey Roger DPres, R, D, CMOS - Sale+OE$199.81-10,00096,853-9%-$1,998,115
DM
2023-03-13
SGENWelch Daniel GDirS - Sale+OE$200.35-27,39731,525-46%-$5,488,901
D
2023-03-09
SGENSimpson Todd ECFOS - Sale+OE$176.61-42,793117,185-27%-$7,557,550
D
2023-03-02
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$177.21-16,215186,728-8%-$2,873,477
2023-02-27
SGENSimpson Todd ECFOS - Sale$182.53-20,000117,185-15%-$3,650,600
D
2023-02-16
SGENSimpson Todd ECFOS - Sale+OE$160.00-39,946137,185-23%-$6,391,400
D
2023-02-16
SGENLiu Jean IGCS - Sale+OE$155.00-5,00085,113-6%-$775,000
D
2023-02-15
SGENDansey Roger DPres, R, D, CMOS - Sale+OE$140.64-10,00096,853-9%-$1,406,395
2023-02-02
SGENDansey Roger DPres, R, D, CMOS - Sale$138.52-78396,853-1%-$108,461
D
2023-01-24
SGENDansey Roger DPres, R, D, CMOS - Sale+OE$135.00-10,00097,539-9%-$1,350,000
D
2023-01-24
SGENLiu Jean IGCS - Sale+OE$135.03-5,00085,113-6%-$675,134
2023-01-17
SGENLiu Jean IGCS - Sale$130.71-57885,113-1%-$75,548
DM
2023-01-04
SGENDansey Roger DPres R, D, CMOS - Sale+OE$135.00-10,00097,539-9%-$1,350,000
DM
2023-01-04
SGENLiu Jean IGCS - Sale+OE$135.00-5,00085,691-6%-$675,000
2022-12-20
SGENRomp Charles REVP, Commercial U.S.S - Sale$127.63-1,12958,475-2%-$144,094
D
2022-12-14
SGENDansey Roger DPres, Research, DeveloS - Sale+OE$135.00-10,00097,539-9%-$1,350,000
D
2022-11-17
SGENLiu Jean IGCS - Sale+OE$131.05-8,33385,691-9%-$1,092,056
2022-11-11
SGENGryska David WDirS - Sale$129.10-7,50040,253-16%-$968,220
D
2022-10-17
SGENDansey Roger DInterim CEO, CMOS - Sale+OE$135.00-10,00097,539-9%-$1,350,000
2022-08-31
SGENSimpson Todd ECFOS - Sale$154.42-4,186137,185-3%-$646,379
2022-08-31
SGENHimes Vaughn BChief Technical OfficerS - Sale$154.42-3,584186,654-2%-$553,422
2022-08-31
SGENRomp Charles REVP, CommercialS - Sale$154.42-1,13359,604-2%-$174,952
2022-08-31
SGENDansey Roger DInterim CEO, CMOS - Sale$154.42-5,01997,539-5%-$775,006
2022-08-31
SGENLiu Jean IGCS - Sale$154.42-3,64884,390-4%-$563,304
2022-08-16
SGENSimpson Todd ECFOS - Sale$170.22-1,967141,371-1%-$334,813
2022-08-16
SGENRomp Charles REVP, CommercialS - Sale$170.22-1,76560,737-3%-$300,430
2022-08-16
SGENLiu Jean IGCS - Sale$170.22-1,63988,038-2%-$278,983
2022-08-16
SGENHimes Vaughn BChief Technical OfficerS - Sale$170.22-1,527190,238-1%-$259,918
2022-08-16
SGENDansey Roger DInterim CEO, CMOS - Sale$170.22-4,254102,558-4%-$724,095
2022-07-05
SGENRomp Charles REVP, CommercialS - Sale$179.46-71248,771-1%-$127,776
D
2022-06-28
SGENDansey Roger DChief Medical OfficerS - Sale+OE$180.00-34,63562,084-36%-$6,234,300
D
2022-06-17
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$160.00-1,134179,669-1%-$181,440
D
2022-05-24
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$136.79-10,866179,669-6%-$1,486,377
2022-05-16
SGENRomp Charles REVP, CommercialS - Sale$134.21-33349,483-1%-$44,691
D
2022-05-12
SGENSiegall Clay BPres, CEOS - Sale+OE$125.69-17,043666,060-2%-$2,142,117

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top